We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
YS Biopharma Company Ltd | NASDAQ:YS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.02 | 1.02 | 1.07 | 0 | 01:00:00 |
GAITHERSBURG, Md., May 18, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it will participate in The Benchmark Company Healthcare House Call Virtual 1x1 Investor Conference on Tuesday, May 23, 2023.
Dr. David Shao, YS Biopharma Chief Executive Officer, Ms. Brenda Wu, YS Biopharma Chief Financial Officer, and Dr. Zenaida Mojares, YS Biopharma Chief Medical Officer, will attend and will be available for virtual one-on-one and small group meetings.
For more information on the conference, please contact your conference representative. Meeting requests may also be emailed to YSBiopharma.IR@icrinc.com.
About YS Biopharma
YS Biopharma is a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA® immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. YS Biopharma operates in China, the United States, Singapore, and the Philippines, and is led by a management team that combines rich local expertise and global experience in the bio-pharmaceutical industry. For more information, please visit investor.ysbiopharm.com.
Investor Relations Contact
Robin Yang
Partner, ICR, LLC
Tel: +1 (212) 537-4035
Email: YSBiopharma.IR@icrinc.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ys-biopharma-to-participate-in-the-virtual-benchmark-healthcare-house-call-conference-on-may-23-2023-301828425.html
SOURCE YS Biopharma Co., Ltd.
Copyright 2023 PR Newswire
1 Year YS Biopharma Chart |
1 Month YS Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions